Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
Francesco Tucci(University of Milan), Salvatore Pece(University of Milan)
Cited by 9
Related Papers
Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
|EMBO Molecular Medicine|2017|44
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer
|Nature Communications|2022|43
Mechanisms of active wetting and fluidification in epithelial cell collectives
|Nature Materials|2026|2